Viking Therapeutics (VKTX) had the highest return between February 10, 2024 and February 28, 2024 by a mid-cap US stock, returning 201.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 2/10/2024 - 2/28/2024 | 201.53% |
SoundHound AI (SOUN) | 2/10/2024 - 2/28/2024 | 179.3% |
GeneDx (WGS) | 2/10/2024 - 2/28/2024 | 97.2% |
Ocular Therapeutix (OCUL) | 2/10/2024 - 2/28/2024 | 71.85% |
BigBearai (BBAI) | 2/10/2024 - 2/28/2024 | 68.82% |
Acm Research (ACMR) | 2/10/2024 - 2/28/2024 | 64.15% |
PureCycle Technologies (PCTTW) | 2/10/2024 - 2/28/2024 | 63.06% |
Arcutis Biotherapeutics (ARQT) | 2/10/2024 - 2/28/2024 | 60.15% |
Beam Therapeutics (BEAM) | 2/10/2024 - 2/28/2024 | 51.69% |
Krystal Biotech (KRYS) | 2/10/2024 - 2/28/2024 | 45.61% |
89bio (ETNB) | 2/10/2024 - 2/28/2024 | 38.52% |
Akero Therapeutics (AKRO) | 2/10/2024 - 2/28/2024 | 36.9% |
Agios Pharm (AGIO) | 2/10/2024 - 2/28/2024 | 33.24% |
Lufax (LU) | 2/10/2024 - 2/28/2024 | 31.88% |
Madrigal Pharmaceuticals (MDGL) | 2/10/2024 - 2/28/2024 | 31.79% |
Lifestance Health (LFST) | 2/10/2024 - 2/28/2024 | 31.57% |
Shake Shack (SHAK) | 2/10/2024 - 2/28/2024 | 29.63% |
Advantage Solutions (ADVWW) | 2/10/2024 - 2/28/2024 | 28.53% |
Dave (DAVE) | 2/10/2024 - 2/28/2024 | 28.52% |
Pagaya Technologies (PGY) | 2/10/2024 - 2/28/2024 | 28.18% |
Recursion Pharmaceuticals (RXRX) | 2/10/2024 - 2/28/2024 | 27.74% |
Vita Coco (COCO) | 2/10/2024 - 2/28/2024 | 27.45% |
CleanSpark (CLSK) | 2/10/2024 - 2/28/2024 | 27.41% |
Cellebrite DI (CLBT) | 2/10/2024 - 2/28/2024 | 27.21% |
Resideo Technologies (REZI) | 2/10/2024 - 2/28/2024 | 26.92% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
